Ftse Mib
33.315,86
1,24%
DAX
18.131,97
0,32%
S&P 500
5.486,12
0,24%
NASDAQ
17.870,58
0,08%
Bitcoin
64.647,77
-2,76%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Journey Medical Corporation (DERM) Journey Medical Corporation (DERM) Notizie

Journey Medical Corporation

DERM
5,44
-0,11 (-1,98%)
Ultimo aggiornamento: 19:14:47
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/5/202422:01GLOBEJourney Medical Corporation to Participate in the Alliance..
14/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:05EDGAR2Form 8-K - Current report
13/5/202422:01GLOBEJourney Medical Corporation Reports First Quarter 2024..
07/5/202414:30GLOBEJourney Medical Corporation to Announce First Quarter 2024..
01/5/202422:01GLOBEJourney Medical Corporation Appoints Joseph Benesch as Chief..
25/4/202414:30GLOBEJourney Medical Corporation to Present at the Planet..
21/3/202421:01GLOBEJourney Medical Corporation Reports Full-Year 2023 Financial..
18/3/202413:30GLOBEJourney Medical Corporation Announces U.S. FDA Acceptance of..
15/3/202413:30GLOBEJourney Medical Corporation to Announce Year End 2023..
13/3/202413:30GLOBEJourney Medical Corporation to Participate in the 36th..
11/3/202413:30GLOBEJourney Medical Corporation Announces Presentation of Data..
23/2/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:30GLOBEJourney Medical Corporation Submits New Drug Application to..
02/1/202422:05EDGAR2Form 8-K - Current report
02/1/202422:05GLOBEJourney Medical Corporation Secures Credit Facility with SWK..
15/12/202322:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/12/202323:01EDGAR2Form 8-K - Current report
06/12/202314:00GLOBEJourney Medical Corporation Announces Successful Completion..
07/11/202322:45EDGAR2Form 8-K - Current report
07/11/202322:01GLOBEJourney Medical Corporation Reports Third Quarter 2023..
31/10/202313:30GLOBEJourney Medical Corporation to Announce Third Quarter 2023..
20/10/202314:30GLOBEJourney Medical Corporation Announces Data from..
17/10/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202315:10EDGAR2Form 8-K - Current report
19/9/202322:59EDGAR2Form 8-K - Current report
08/9/202319:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202314:00EDGAR2Form 8-K - Current report
06/9/202314:00GLOBEJourney Medical Corporation Enters into an Exclusive License..
18/8/202323:00EDGAR2Form 8-K - Current report
14/8/202322:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
10/8/202322:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:06EDGAR2Form 8-K - Current report
08/8/202322:01GLOBEJourney Medical Corporation Reports Second Quarter 2023..
02/8/202322:01GLOBEJourney Medical Corporation to Announce Second Quarter 2023..
26/7/202314:30EDGAR2Form 8-K - Current report
25/7/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202314:30GLOBEJourney Medical Corporation to Announce Second Quarter 2023..
11/7/202314:30GLOBEJourney Medical Corporation Announces Positive Topline..
03/7/202314:00GLOBEJourney Medical Corporation Expects Topline Results from the..
Apertura: 5,59 Min: 5,3601 Max: 5,635
Chiusura: 5,55

La tua Cronologia

NASDAQ
DERM
Journey Medical
TG
A2YN1H
Infineon Technologies
BIT
P1KVH1
BNP Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network